Jung-Jin Lee Selected Research

Jung-Jin Lee Research Topics

Disease

7	Atherosclerosis 07/2016 - 04/2007
6	Thrombosis (Thrombus) 01/2017 - 01/2008
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 04/2007
4	Inflammation (Inflammations) 01/2021 - 08/2012
4	Neointima 01/2017 - 04/2010
4	Insulin Resistance 08/2012 - 01/2010
3	Neoplasms (Cancer) 01/2020 - 04/2007
3	Type 2 Diabetes Mellitus (MODY) 08/2012 - 01/2011
3	Hyperplasia 01/2011 - 04/2010
2	Neuroinflammatory Diseases 12/2020 - 01/2020
2	Stroke (Strokes) 01/2020 - 01/2012
2	Reperfusion Injury 01/2020 - 06/2018
2	Coronary Disease (Coronary Heart Disease) 01/2019 - 12/2016
2	Vascular Diseases (Vascular Disease) 01/2017 - 11/2008
2	Obesity 09/2016 - 01/2015
2	Body Weight (Weight, Body) 07/2016 - 01/2015
2	Carotid Artery Injuries 12/2014 - 06/2010
2	Stomach Ulcer (Gastric Ulcer) 12/2012 - 12/2009
2	Carcinoma (Carcinomatosis) 08/2012 - 01/2010
2	Diabetes Mellitus 08/2012 - 01/2010
1	Pain (Aches) 11/2021
1	Dysbiosis 03/2021
1	Sepsis (Septicemia) 03/2021
1	Congenital Hyperinsulinism 01/2021
1	Periodontitis 01/2021
1	Clostridium Infections 01/2021
1	Leg Ulcer 01/2021
1	Hypoglycemia (Reactive Hypoglycemia) 01/2021
1	Cognitive Dysfunction 12/2020
1	Brain Neoplasms (Brain Tumor) 01/2020
1	Kidney Calculi (Kidney Stone) 01/2020
1	Cytokine Release Syndrome 01/2019
1	Myocardial Infarction 01/2019
1	Ischemic Stroke 06/2018
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 06/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Atherosclerotic Plaque (Atheroma) 07/2016

Drug/Important Bio-Agent (IBA)

4	CollagenIBA 12/2014 - 10/2006
4	Glucose (Dextrose)FDA LinkGeneric 08/2012 - 01/2010
4	Becaplermin (PDGF-BB)FDA Link 02/2012 - 04/2007
3	Anti-Bacterial Agents (Antibiotics)IBA 11/2021 - 01/2019
3	LipidsIBA 01/2019 - 01/2015
3	Pharmaceutical PreparationsIBA 09/2016 - 03/2010
3	obovatolIBA 12/2012 - 12/2009
3	Biological ProductsIBA 12/2012 - 12/2009
3	Insulin (Novolin)FDA Link 08/2012 - 01/2010
3	FlavonoidsIBA 01/2012 - 04/2007
3	Fenofibrate (CiL)FDA LinkGeneric 04/2011 - 10/2009
2	LipopolysaccharidesIBA 03/2021 - 12/2020
2	EnzymesIBA 12/2020 - 09/2016
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2017 - 01/2011
2	Proteins (Proteins, Gene)FDA Link 09/2016 - 01/2011
2	Adenosine Diphosphate (ADP)IBA 12/2014 - 10/2006
2	soshiho-tangIBA 02/2014 - 06/2013
2	Anti-Allergic Agents (Antiallergic Agents)IBA 12/2012 - 12/2009
2	AntioxidantsIBA 01/2012 - 04/2007
2	ThromboxanesIBA 01/2012 - 10/2009
2	CalciumIBA 10/2009 - 01/2008
1	Therapeutic UsesIBA 11/2021
1	Vancomycin FDA LinkGeneric 11/2021
1	Formaldehyde (Formol)FDA Link 11/2021
1	Drinking WaterIBA 11/2021
1	Volatile Fatty AcidsIBA 03/2021
1	hexanoic acid (hexanoate)IBA 03/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2021
1	propionic acid (potassium propionate)IBA 03/2021
1	16S Ribosomal RNAIBA 01/2021
1	Bile Acids and Salts (Bile Acids)IBA 01/2021
1	Amoxicillin (Wymox)FDA LinkGeneric 01/2021
1	Metronidazole (Metric)FDA LinkGeneric 01/2021
1	TeaIBA 12/2020
1	EndotoxinsIBA 12/2020
1	ImmunosorbentsIBA 12/2020
1	Butyrates (Butyrate)IBA 01/2020
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2020
1	ApoferritinsIBA 01/2020
1	Calcium OxalateIBA 01/2020
1	Contrast MediaIBA 01/2020
1	GadoliniumIBA 01/2020
1	OxalatesIBA 01/2020
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2020
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 06/2018
1	Etoposide (VP 16)FDA LinkGeneric 06/2018
1	AndrogensIBA 01/2018
1	SteroidsIBA 01/2018
1	PregnenoloneIBA 01/2018
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 12/2016
1	LeptinIBA 09/2016
1	Phosphotransferases (Kinase)IBA 09/2016
1	oil red OIBA 09/2016
1	Triglycerides (Triacylglycerol)IBA 07/2016
1	murrayafoline AIBA 09/2015

Therapy/Procedure

3	Oral Administration 12/2020 - 12/2014
2	Fecal Microbiota Transplantation 11/2021 - 01/2021
2	Therapeutics 01/2021 - 01/2020
1	Root Planing 01/2021
1	Pancreatectomy 01/2021
1	Transplantation 01/2021
1	Stents 01/2017